Dementia with Lewy bodies: An emerging disease

American Family Physician

Volumn 73, Issue 7, 2006, Pages 1223-1230

  Neef, Doug ^a,c   Walling, Anne D ^a,b  

^a Via Christi Family Medicine Residency ^*  (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^c Family Medicine Residency Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBIDOPA PLUS LEVODOPA; CHLORPROMAZINE; CHOLINESTERASE INHIBITOR; CLONAZEPAM; DOPAMINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; RIVASTIGMINE;

ALZHEIMER DISEASE; ARTICLE; ATAXIA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DELIRIUM; DELUSION; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; GASTROINTESTINAL SYMPTOM; HUMAN; LEWY BODY; NEUROTRANSMISSION; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PARKINSONISM; PRACTICE GUIDELINE; RIGIDITY; SEDATION; SIDE EFFECT; SLEEP DISORDER; SYMPTOMATOLOGY; SYNCOPE; VISUAL HALLUCINATION;

ACETYLCHOLINE; DIAGNOSIS, DIFFERENTIAL; DOPAMINE; HUMANS; LEWY BODIES; LEWY BODY DISEASE; PROGNOSIS;

EID: 33645543268     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kosaka K, Yoshimura M, Ikeda K, Budka H. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease? Clin Neuropathol 1984;3:185-92.
2. Stewart JT. Defining diffuse Lewy body disease. Tetrad of symptoms distinguishes illness from other dementias. Postgrad Med 2003;113:71-5.
3. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
4. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol 2004;3:19-28.
5. National Institute of Neurological Disorders and Strokes. NINDS dementia with lewy bodies information page. Accessed online July 27, 2005, at: http://www.ninds.nih.gov/disorders/dementiawithlewybodies/ dementiawithlewybodies.htm.
6. Neuropathology Group. Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001;357:169-75.
7. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-9.
8. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease [published correction appears in N Engl J Med 2003;348:2588]. N Engl J Med 2003;348:1356-64.
9. Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VM, et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84.
10. Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001;58:186-90.
11. Leverenz JB, McKeith IG. Dementia with Lewy bodies. Med Clin North Am 2002;86:519-35.
12. Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Neurology 2001;56:1143-53.
13. Larson EB. An 80-year-old man with memory loss [published correction appears in JAMA 2000;284:3129]. JAMA 2000;283:1046-53.
14. Knopman DS, Boeve BF, Petersen RC. Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 2003;78:1290-308.
15. Mosimann UP, McKeith IG. Dementia with Lewy bodies - diagnosis and treatment. Swiss Med Wkly 2003;133:131-42.
16. Ballard CG, Ayre G, O'Brien J, Sahgal A, McKeith IG, Ince PG, et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1999;10:104-8.
17. Walker MP, Ayre GA, Perry EK, Wesnes K, McKeith IG, Tovee M, et al. Quantification and characterization of fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:327-35.
18. Ferman TJ, Smith GE, Boeve BF, Ivnik RJ, Petersen RC, Knopman D, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004;62:181-7.
19. Ferman TJ, Boeve BF, Smith GE, Silber MH, Lucas JA, Graff-Redford NR, et al. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 2002;8:907-14.
20. Boeve BF, Silber MH, Ferman TJ. REM sleep behavior disorder in Parkinson's disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 2004;17:146-57.
21. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123(pt 2):331-9.
22. Del-Ser T, Munoz DG, Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 1996;46:682-6.
23. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Neurology 1999;53:902-5.
24. Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease. Mov Disord 2003;18(suppl 6):S72-9.
25. Kalra S, Bergeron C, Lang AE. Lewy body disease and dementia. A review. Arch Intern Med 1996;156:487-93.
26. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, et al. Practice parameter: management of dementia (an evidence-based review). Report of Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1154-66.
27. McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000;356:2031-6.
28. Wild R, Pettit T, Burns A. Cholinesterase inhibitors for dementia with Lewy bodies. Cochrane Database Syst Rev 2003;(3):CD003672.
29. McKeith I, Fairbairn A, Perry R, Thompson P, Perry E. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992;305:673-8.
30. McShane R, Keene J, Gedling K, Fairburn C, Jacoby R, Hope T. Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up. BMJ 1997;314:266-70.
31. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596-608.
32. Ballard C, O'Brien J, Morris CM, Barber R, Swann A, Neill D, et al. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001;16:499-503.
33. Walker Z, Allen RL, Shergill S, Mullan E, Katona CL. Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies. Int J Geriatr Psychiatry 2000;15:267-73.